James L Ferrara | Icahn School of Medicine

Biography

Research Topics

Cytokines, Immunological Tolerance, Immunology, Inflammation, Stem Cells, Transplantation

Multi-Disciplinary Training Area

Cancer Biology [CAB], Immunology [IMM]

Publications

309

Publications

Selected Publications

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD. Yu Akahoshi, Joseph Portelli, Nikolaos Katsivelos, Ioannis E. Louloudis, Paibel Aguayo-Hiraldo, Francis Ayuk, Chantiya Chanswangphuwana, Hannah K. Choe, Matthias Eder, Aaron M. Etra, Elizabeth O. Hexner, Carrie L. Kitko, Sabrina Kraus, Pietro Merli, Timothy S. Olson, Ivan Pasic, Muna Qayed, Ran Reshef, Tal Schechter, Julia Marx, Evelyn Ullrich, Ingrid Vasova, Daniela Weber, Matthias Wölfl, Robert Zeiser, Janna Baez, Gilbert Eng, Sigrun Gleich, Steven Kowalyk, George Morales, Nikolaos Spyrou, Rachel Young, Zachariah DeFilipp, William J. Hogan, Ryotaro Nakamura, John E. Levine, James L.M. Ferrara. Blood advances

Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD. Aaron Etra, James L.M. Ferrara, John E. Levine. Blood

Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC. Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, Hideki Nakasone, Marcio A. Diniz, Noboru Asada, Francis Ayuk, Hannah K. Choe, Noriko Doki, Tetsuya Eto, Aaron M. Etra, Elizabeth O. Hexner, Nobuhiro Hiramoto, William J. Hogan, Ernst Holler, Keisuke Kataoka, Toshiro Kawakita, Masatsugu Tanaka, Takashi Tanaka, Naoyuki Uchida, Ingrid Vasova, Satoshi Yoshihara, Fumihiko Ishimaru, Takahiro Fukuda, Yi Bin Chen, Junya Kanda, Ryotaro Nakamura, Yoshiko Atsuta, James L.M. Ferrara, Yoshinobu Kanda, John E. Levine, Takanori Teshima. Blood advances

View All Publications

Video

Office Locations

Hess CSM Building Floor 6th Floor

1470 Madison Ave

New York, NY 10029

212-824-9365

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ferrara during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Realta Life Sciences
Incyte Corporation
IQVIA

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Ferrara during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

Realta Life Sciences
Incyte Corporation
IQVIA

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.